Podcast Episodes
Back to SearchDay One DNA: How and why the UK is betting on whole genome sequencing for every newborn
Episode 159
The UK is preparing to change the game for healthcare - but why, how, and what will it cost?
Recently the UK government announced plans to sequence th…
1 year, 2 months ago
Meatly's innovative cultivated meat is already delighting pets, are humans next?
Episode 158
Is cultivated meat the future of pet food? And is there a place for cultivated meat on human dinner tables, too?
Traditional agricultural methods are …
1 year, 2 months ago
Cryoport Systems on the state of the ATMP market and the importance of supply chain resilience
Episode 157
With supply chain management and optimization, risk management, and the capacity to address global markets efficiently and effectively top of mind fo…
1 year, 2 months ago
Taking the fight to inflammatory disease: InflaRx’s first-in-class C5a/C5aR signaling pathway strategy
Episode 156
Inflammatory diseases involve excessive or ongoing inflammation that damages tissues and affects many different human systems, including digestion, i…
1 year, 2 months ago
How OMass Therapeutics is tackling congenital adrenal hyperplasia, a rare genetic disorder
Episode 155
Ros Deegan is an industry leader and the CEO of OMass Therapeutics, an Oxford-based biotechnology company discovering medicines against highly-valida…
1 year, 3 months ago
Persica Pharmaceuticals is treating the cause of chronic lower back pain, not just the symptoms
Episode 154
The World Health Organization reports that more than 600 million people suffer from lower back pain globally, making it the leading cause of disabili…
1 year, 3 months ago
Humacyte: Saving lives with lab-grown blood vessels in conflict zones
Episode 153
Trauma surgeons in Ukraine operating theaters saved lives and limbs thanks to the innovative lab-grown blood vessels from US biotech, Humacyte.
Humacy…
1 year, 3 months ago
Special Episode: The 2025 BIO International Convention
Episode 152
Much of the attention of the biotech industry has been focused on the city of Boston this week as the annual BIO International Convention hit town.
B…
1 year, 3 months ago
Alex Telford on AI, drug discovery, digital twins, and the most interesting questions in biotech
Episode 151
What are the most interesting questions in biotech, and is it even possible to find answers to those questions?
Alex Telford is the co-founder of Conv…
1 year, 4 months ago
Corporate venture capital and biotechnology in 2025: challenges, opportunities, and threats
Episode 150
When biotechs start fundraising they regularly turn to the venture capital market seeking investment. The pool of VC money can be large, and part of …
1 year, 4 months ago